← Back to Search

Experimental Group for Cerebral Palsy

N/A
Waitlist Available
Led By Peter J Barrance, PhD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day (at single time point)
Awards & highlights
No Placebo-Only Group

Summary

This study aims to assess the feasibility of a visual feedback system designed to augment treadmill-based gait training for children with gait disturbances related to hemiplegic cerebral palsy. The visual feedback uses data from knee and hip joint movements to represent the position of the foot ahead of or behind the body during walking. This study will test eight children with hemiplegic cerebral palsy who have short step lengths related to atypical knee and hip motions when the foot contacts the ground (initial contact). The study will examine walking adaptations in response to the new visual feedback system and compare differences in response and user experience between two variants of the new design. In a single visit, participants will undergo a gait retraining protocol using the dual joint visual feedback (DJVF) system. Hip and knee flexion angles of the paretic (weaker) side will be collected, analyzed, and compared during baseline walking and while responding to the two feedback variants. Muscle firing patterns will be studied using electrodes placed on key lower limb muscles. Study participants will be asked to report their experience and preferences following the gait retraining protocol. The study findings will be used to further refine the DJVF system in preparation for future studies.

Eligible Conditions
  • Cerebral Palsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day (at single time point)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day (at single time point) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hip flexion angle at initial contact during FBC exposure
Hip flexion angle at initial contact during FBCS exposure
Hip flexion angle at initial contact without feedback
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental GroupExperimental Treatment2 Interventions
Participants will undergo a single testing session of gait retraining using two variants of the dual joint visual feedback system (DJVF). The DJVF system uses IMU sensors to measure knee and hip joint motions and calculates the users foot position, relative to their pelvis. The relative foot position is represented in real time on a screen in front of the user with feedback designed to elicit increases in anteriorly located foot positions.

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
181 Previous Clinical Trials
11,071 Total Patients Enrolled
Children's Specialized HospitalOTHER
5 Previous Clinical Trials
201 Total Patients Enrolled
Peter J Barrance, PhDPrincipal InvestigatorKessler Foundation
~2 spots leftby Nov 2025